FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Biologics

Greater FDA Oversight of SCRI Products Needed, Pew Says

A Pew Charitable Trusts report details adverse events reported by patients using unapproved stem cell and regenerative medicine interventions and call...

Human Drugs

Court Finds Zofran Suit Preempted by Federal Law

The Massachusetts federal court grants summary judgment to GlaxoSmithKline and dismisses as preempted a suit claiming the company failed to warn pregn...

Medical Devices

CDRH ASCA Pilot on Schedule, Expecting Submissions

CDRH ASCA team member Angela DeMarco says the ASCA pilot program is on schedule with 53 test labs accredited.

Medical Devices

De Novo Granted for Autism Diagnosis Aid

FDA grants a de novo marketing authorization request to Cognoa for its Cognoa ASD Diagnosis Aid to help diagnose autism spectrum disorder.

Medical Devices

AFib Patients with Wearable Devices Use More Health Resources: Study

Researchers say that atrial fibrillation patients who use smartwatches or other wearable devices to manage their condition make greater follow-up use ...

Medical Devices

Issues at Italys Steril Milano Sterilization Facility

FDA says 97 medical device manufacturers may be affected by sterility issues at the now-closed Steril Milano ethylene oxide sterilization facilities i...

Human Drugs

Scynexis Yeast Infection Drug Approved

FDA approves a Scynexis NDA for Brexafemme (ibrexafungerp) tablets for oral use in patients with a vaginal yeast infection.

Human Drugs

Reverse Dietary Supplement NAC Ban: Petition

The Council for Responsible Nutrition says FDA should revert to its prior policy allowing NAC to be sold as a dietary supplement.

Biologics

Biosimilar Program at FDA Maturing: Woodcock

FDA acting commissioner Janet Woodcock says biosimilar product development is maturing with the help of numerous initiatives at the agency.

Biologics

FDA Finds HCT/P Deviations at Utah Cord Bank

FDA warns Utah Cord Bank about significant deviations from the regulations for human cells, tissues, and cellular and tissue-based products.